Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,200 | 11,626 | 10,517 | 53,068 | 17,306 |
| Marketable Securities | 19,574 | 23,261 | 33,084 | 0 | 8,578 |
| Inventories | 3,729 | 4,414 | 3,974 | 4,437 | 3,447 |
| Other current assets | 173 | 1,008 | 1,018 | 278 | 129 |
| TOTAL | $41,785 | $43,348 | $51,506 | $60,147 | $30,913 |
| Non-Current Assets | |||||
| PPE Net | 13,953 | 15,017 | 15,782 | 14,334 | 14,991 |
| Other Non-Current Assets | 5,822 | 7,432 | 9,044 | 10,889 | 1,168 |
| TOTAL | $19,775 | $22,449 | $24,826 | $25,223 | $16,159 |
| Total Assets | $61,560 | $65,797 | $76,332 | $85,370 | $47,072 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,799 | 1,692 | 2,655 | 3,405 | 3,789 |
| Accrued Expenses | 875 | 557 | 342 | 100 | 178 |
| Other current liabilities | 1,700 | 1,400 | 1,100 | 2,400 | 2,500 |
| TOTAL | $11,517 | $10,993 | $9,694 | $13,179 | $14,898 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,450 | 2,374 | 1,457 | 3,215 | 2,915 |
| Other Non-Current Liabilities | 30,085 | 32,929 | 31,876 | 37,967 | 36,815 |
| TOTAL | $101,696 | $103,643 | $102,997 | $103,468 | $56,149 |
| Total Liabilities | $113,213 | $114,636 | $112,691 | $116,647 | $71,047 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,405 | 19,405 | 17,371 | 17,320 | 17,283 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -410,960 | -404,253 | -390,925 | -384,963 | -374,228 |
| Other shareholders' equity | -3 | -1 | 2 | 0 | 1 |
| TOTAL | $-51,653 | $-48,839 | $-36,359 | $-31,277 | $-23,975 |
| Total Liabilities And Equity | $61,560 | $65,797 | $76,332 | $85,370 | $47,072 |